|
Persistent Identifier
|
perma:LIST.5HBVBO |
|
Publication Date
|
2026-07-06 |
|
Title
| PHOENIX-OITB – Developing and upgrading innovative nanopharmaceuticals from bench to clinics [* Cross-Reference *] |
|
Other Identifier
| DataCite: https://doi.org/10.5281/zenodo.16977381 |
|
Author
| Resch, Susanne (BioNanoNet Forschungsgesellschaft mbH)BioNanoNet Forschungsgesellschaft mbHORCID0000-0003-1016-5979
Scheper, Johanna K. (BioNanoNet Forschungsgesellschaft mbH)BioNanoNet Forschungsgesellschaft mbHORCID0000-0003-2410-2936
Cordoba, Alba (Nanomol Technologies)Nanomol TechnologiesORCID0000-0002-2726-5119
Font, Albert (Leanbio S.L.)
Ventosa, Nora (ICMAB-CSIC, Centro de Investigación Biomédica en Red)ICMAB-CSIC, Centro de Investigación Biomédica en RedORCID0000-0002-8008-4974
de la Fuente, Jesus M (Consejo Superior de Investigaciones Científicas)Consejo Superior de Investigaciones CientíficasORCID0000-0003-1081-8482
Vinkovic Vrcek, Ivana (University of Rijeka, Institute for Medical Research and Occupational Health)University of Rijeka, Institute for Medical Research and Occupational HealthORCID0000-0003-1382-5581
Srinivas, Mangala (Wageningen University & Research, Cenya Imaging BV)Wageningen University & Research, Cenya Imaging BVORCID0000-0002-3835-1995
Mohsenzada, Sulaiman (Research Center Pharmaceutical Engineering (Austria))
Schröter, Christian (Topas GmbH (Germany))
Holzer, Robert (Research Center for Non Destructive Testing (Austria))
Serchi, Tommaso (Luxembourg Institute of Science and Technology)Luxembourg Institute of Science and TechnologyORCID0000-0003-2386-3514
Günday-Türeli, Nazende (MyBiotech GmbH)MyBiotech GmbHORCID0000-0002-6310-4785 |
|
Point of Contact
|
Use email button above to contact.
LIST QDKM (LIST) |
|
Description
| The PHOENIX Open Innovation Test Bed (PHOENIX-OITB) is focused on overcoming the challenges of production of novel and innovative nano-pharmaceuticals (NPs) from lab scale to GMP quality and production, maximising bioavailability, stability and manufacturing to allow their implementation in the medicine field. PHOENIX-OITB is a non-profit, open and self-sustaining legal entity that works as a Single Entry Point (SEP) providing its end-users transparent processes and procedures as well as easy access to services and expertise needed to bridge the gapbetween the bench and the bedside, i.e., providing them with high-quality services, capable of Quality-Efficacy and Safety (QES) evaluation and production of nano-pharmaceuticals at large scales, meeting the regulatory and GMP requirements. (2025-08-28)
***This entry has been automatically imported via Datacite by LIST harvest scripts. Please refer to https://doi.org/10.5281/zenodo.16977381 for the original and latest version of the dataset and data downloads*** (2025-09-02) |
|
Subject
| Earth and Environmental Sciences; Medicine, Health and Life Sciences |
|
Keyword
| Nanomedicine (MeSH) |
|
Related Publication
| References: (HasVersion) 10.5281/zenodo.16977382 https://doi.org/10.5281/zenodo.16977382 |
|
Funding Information
| European Commission: 953110 ("Pharmaceutical Open Innovation Test Bed for Enabling Nano-pharmaceutical Innovative Products") |
|
Deposit Date
| 2025-08-28 |
|
Data Type
| Text |